The role of acid-base imbalance in statin-induced myotoxicity

被引:26
|
作者
Taha, Dhiaa A.
De Moor, Cornelia H.
Barrett, David A.
Lee, Jong Bong
Gandhi, Raj D.
Hoo, Chee Wei
Gershkovich, Pavel
机构
[1] Univ Nottingham, Sch Pharm, Div Med Chem & Struct Biol, Nottingham, England
[2] Univ Nottingham, Sch Pharm, Div Mol & Cellular Sci, Nottingham, England
基金
英国生物技术与生命科学研究理事会;
关键词
COA REDUCTASE INHIBITORS; SKELETAL-MUSCLE; CHROMATOGRAPHIC METHODS; INDUCED MYOPATHY; SIMVASTATIN; VALIDATION; TOXICITY; PH; CYTOTOXICITY; LOVASTATIN;
D O I
10.1016/j.trsl.2016.03.015
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Disturbances in acid-base balance, such as acidosis and alkalosis, have potential to alter the pharmacologic and toxicologic outcomes of statin therapy. Statins are commonly prescribed for elderly patients who have multiple comorbidities such as diabetes mellitus, cardiovascular, and renal diseases. These patients are at risk of developing acid-base imbalance. In the present study, the effect of disturbances in acid-base balance on the interconversion of simvastatin and pravastatin between lactone and hydroxy acid forms have been investigated in physiological buffers, human plasma, and cell culture medium over pH ranging from 6.8-7.8. The effects of such interconversion on cellular uptake and myotoxicity of statins were assessed in vitro using C2C12 skeletal muscle cells under conditions relevant to acidosis, alkalosis, and physiological pH. Results indicate that the conversion of the lactone forms of simvastatin and pravastatin to the corresponding hydroxy acid is strongly pH dependent. At physiological and alkaline pH, substantial proportions of simvastatin lactone (SVL; similar to 87% and 99%, respectively) and pravastatin lactone (PVL; similar to 98% and 99%, respectively) were converted to the active hydroxy acid forms after 24 hours of incubation at 37 degrees C. At acidic pH, conversion occurs to a lower extent, resulting in greater proportion of statin remaining in the more lipophilic lactone form. However, pH alteration did not influence the conversion of the hydroxy acid forms of simvastatin and pravastatin to the corresponding lactones. Furthermore, acidosis has been shown to hinder the metabolism of the lactone form of statins by inhibiting hepatic microsomal enzyme activities. Lipophilic SVL was found to be more cytotoxic to undifferentiated and differentiated skeletal muscle cells compared with more hydrophilic simvastatin hydroxy acid, PVL, and pravastatin hydroxy acid. Enhanced cytotoxicity of statins was observed under acidic conditions and is attributed to increased cellular uptake of the more lipophilic lactone or unionized hydroxy acid form. Consequently, our results suggest that comorbidities associated with acid-base imbalance can play a substantial role in the development and potentiation of statin-induced myotoxicity.
引用
收藏
页码:140 / 160
页数:21
相关论文
共 50 条
  • [31] Statin-induced rhabdomyolysis
    Schreiber, Donald H.
    Anderson, Thomas R.
    [J]. JOURNAL OF EMERGENCY MEDICINE, 2006, 31 (02): : 177 - 180
  • [32] Effects of acid-base imbalance on vascular reactivity
    Celotto, C.
    Capellini, V. K.
    Baldo, C. F.
    Dalio, M. B.
    Rodrigues, A. J.
    Evora, P. R. B.
    [J]. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2008, 41 (06) : 439 - 445
  • [33] STATIN-INDUCED MYTOTOXICITY
    Pirmohamed, Munir
    [J]. DRUG METABOLISM AND PHARMACOKINETICS, 2017, 32 (01) : S10 - S10
  • [34] STATIN-INDUCED RHABDOMYOLYSIS WITHOUT THE STATIN?
    Dubuc, J.
    Traina, A.
    Moise, H. Oddo
    Bourgeois, A.
    Coulon, A.
    Doan, J.
    Guillory, S.
    Sanne, S.
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2018, 66 (02) : 610 - 611
  • [35] Statin-induced Myopathy
    Kandzia, I.
    Kowar, M.
    Jacobs, A. H.
    [J]. ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 2018, 51 : 139 - 139
  • [36] Statin-induced hepatotoxicity
    Kaplowitz, N
    [J]. GASTROENTEROLOGY, 2004, 127 (04) : 1278 - 1278
  • [37] Statin-induced myopathies
    Tomaszewski, Michal
    Stepien, Karolina M.
    Tomaszewska, Joanna
    Czuczwar, Stanislaw J.
    [J]. PHARMACOLOGICAL REPORTS, 2011, 63 (04) : 859 - 866
  • [38] Statin-induced myopathies
    Michał Tomaszewski
    Karolina M. Stępień
    Joanna Tomaszewska
    Stanisław J. Czuczwar
    [J]. Pharmacological Reports, 2011, 63 : 859 - 866
  • [39] Statin-induced Myotoxicity: Update on Case Characteristics and Recruitment Efficiency in a Clinical Practice-based Setting
    Mareedu, Ravi K.
    Modhia, Falgun M.
    Krauss, Ronald M.
    McCarty, Catherine A.
    Wilke, Russell A.
    [J]. FASEB JOURNAL, 2008, 22
  • [40] Role of thyroid disease in the development of statin-induced myopathy
    Rush, Jordan
    Danzi, Sara
    Klein, Irwin
    [J]. ENDOCRINOLOGIST, 2006, 16 (05): : 279 - 285